Avik Pal, CliniOps' CEO, expressed enthusiasm for the collaboration, stating, 'This partnership is an exciting opportunity for CliniOps and Indegene to complement each other's strengths, to ultimately ...

Under the terms of the deal, Alchemab and Lilly will work together on up to five new antibodies, according to a Jan. 9 ...

With a state grand jury report released Wednesday, Florida Gov. Ron DeSantis doubled down on the message he delivered often ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

Naltrexone is not the only drug used to treat alcoholism, but its high success rate and lack of substantial side effects are ...

This morning, the Twenty-Second Statewide Grand Jury released its final report. This Grand Jury was tasked with investigating ...

Just when you thought there couldn’t be investor appetite for yet another GLP-1-focused obesity biotech, Verdiva Bio has ...

When Anne Maldzinski underwent a blood stem-cell transplant to cure her cancer, the procedure triggered a life-threatening ...

Hippocratic AI is kicking off 2025 with a bang. The startup, which is building a large language model specifically for healthcare use cases, banked a $141 million series B financing round only nine ...

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...

About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...

Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...